Product Description
Since last manyyears SaintroyLifescienceis leading manufacture, export andsupplier ofAmsacrine Injectionfrom Surat, Gujarat, India. Amsacrine Injection used in acute lymphoblastic leukemia.
Tags: Amsacrine Injection manufacturer, Amsacrine Injection exporter,Amsacrine Injection supplier, and Amsacrine Injection, whogmp approved Amsacrine Injectionmanufacturer and supplier, Amsacrine Injection distributor, Amsacrine Injectionshipper, Amsacrine Injection 1.5 ml Amsacrine Injection 1.5 mlsupplier,Amsacrine Injection 1.5 ml.
ISO/GMP/cGMP/WHOGMP/NAFDAC approved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility inGujarat, India.
Registration: Saintroy Lifescienceis interested inregistration of own brand or customer brands in ministryof health of clientscountry and we also provide the products samples, COA, COPP, ACTD or CTD dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country:Saintroy LifescienceAmsacrine Injection export toUSA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal,Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger,Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Intravenous Therapy for Acute Myeloid LeukemiaAmsacrine Injection is formulated specifically for the treatment of leukemic conditions, particularly Acute Myeloid Leukemia (AML). Administered intravenously, it functions as an antitumor antibiotic, disrupting the growth of cancer cells. Designed strictly for use by medical professionals, this product allows for controlled and targeted dosing, ensuring efficacy and safety through monitored administration.
Quality and Safety in Every VialProduced under stringent quality control as per therapeutic requirements, Amsacrine Injection comes in a clear yellowish solution. It is highly water soluble and has a stable pH of 3.0 to 4.0, ensuring compatibility with intravenous administration. Monitoring of liver, kidney, and blood counts during therapy is advised to optimize treatment outcomes and minimize side effects.
FAQ's of Amsacrine Injection:
Q: How is Amsacrine Injection administered?
A: Amsacrine Injection is intended for intravenous use only and must be administered by qualified healthcare professionals within a clinical setting.
Q: What is Amsacrine Injection used for?
A: This medication is primarily used in the treatment of leukemia, especially Acute Myeloid Leukemia, as part of antineoplastic (anticancer) therapy.
Q: When should the therapy with Amsacrine be monitored?
A: Blood counts, as well as liver and kidney function, must be regularly monitored throughout the course of Amsacrine therapy to ensure patient safety and detect potential side effects early.
Q: Where should Amsacrine Injection be stored?
A: The vials should be stored in a cool, dry place away from direct sunlight to preserve their shelf life, which is 2 years from the date of manufacture.
Q: What is the process for using Amsacrine Injection?
A: The injection is given intravenously by a healthcare provider. Dosage and administration schedule should strictly follow the prescribing oncologist's guidelines and hospital protocols.
Q: What are the main benefits of using Amsacrine Injection?
A: Amsacrine Injection offers targeted antitumor action for acute leukemias, making it a vital component of specific chemotherapy regimens. Its water solubility and clarity ensure reliable dosing and effectiveness in treatment.